Sonoma Pharmaceuticals Correlations

SNOA Stock  USD 3.23  0.25  7.18%   
The current 90-days correlation between Sonoma Pharmaceuticals and China Pharma Holdings is 0.01 (i.e., Significant diversification). The correlation of Sonoma Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Sonoma Pharmaceuticals Correlation With Market

Good diversification

The correlation between Sonoma Pharmaceuticals and DJI is -0.04 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Sonoma Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sonoma Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
For information on how to trade Sonoma Stock refer to our How to Trade Sonoma Stock guide.

Moving against Sonoma Stock

  0.47ZVSA ZyVersa TherapeuticsPairCorr
  0.46LYRA Lyra TherapeuticsPairCorr
  0.43KRON Kronos BioPairCorr
  0.4OCEAW Ocean BiomedicalPairCorr
  0.35CDIOW Cardio DiagnosticsPairCorr
  0.32ELEV Elevation OncologyPairCorr
  0.32LLY Eli LillyPairCorr
  0.37ABUS Arbutus Biopharma CorpPairCorr
  0.32PMVP Pmv PharmaceuticalsPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
SBFMPTPI
PTPIUPC
SBFMUPC
TKNOPTPI
TKNOSBFM
MSMYLOVFF
  
High negative correlations   
LOVFFUPC
LOVFFSBFM
LOVFFPTPI
MSMYPTPI
MSMYUPC
LOVFFTKNO

Risk-Adjusted Indicators

There is a big difference between Sonoma Stock performing well and Sonoma Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Sonoma Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
CPHI  6.90  0.76  0.10 (0.55) 6.95 
 20.83 
 45.32 
UPC  6.36 (2.90) 0.00  1.11  0.00 
 8.33 
 62.86 
ACOR  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
AKAN  3.27  0.24  0.04  0.08  3.88 
 8.28 
 25.81 
PTPI  8.38 (1.52) 0.00  0.27  0.00 
 14.29 
 136.91 
SBFM  3.15 (0.07) 0.00 (0.10) 0.00 
 7.91 
 24.99 
GHSI  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
TKNO  4.11 (0.21) 0.00 (0.17) 0.00 
 7.31 
 24.03 
LOVFF  3.19  1.08  0.25  1.27  2.37 
 13.64 
 26.17 
MSMY  7.37  1.38  0.06 (0.72) 8.53 
 25.00 
 124.44 

Sonoma Pharmaceuticals Corporate Management

Jerome DvonchInterim OfficerProfile
John PoggettoControllerProfile
Jerome CPAChief OfficerProfile
Victoria CovelAssistant ControllerProfile